JUNS
Income statement / Annual
Last year (2025), Jupiter Neurosciences Inc's total revenue was $21.80 K,
and the percentage change from the previous year is not available.
In 2025, Jupiter Neurosciences Inc's net income was -$8.64 M.
See Jupiter Neurosciences Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$21.80 K |
$0.00 |
$0.00 |
$233.28 K |
$638.04 K |
$1.13 M |
$0.00 |
| Cost of Revenue |
$4.23 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$17.57 K
|
$0.00
|
$0.00
|
$233.28 K
|
$638.04 K
|
$1.13 M
|
$0.00
|
| Gross Profit Ratio |
0.81
|
0
|
0
|
1
|
1
|
1
|
0
|
| Research and Development Expenses |
$2.09 M
|
$492.66 K
|
$954.79 K
|
$942.81 K
|
$1.45 M
|
$1.64 M
|
$685.74 K
|
| General & Administrative Expenses |
$6.84 M
|
$2.60 M
|
$2.92 M
|
$2.72 M
|
$3.10 M
|
$1.34 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.84 M
|
$2.60 M
|
$2.92 M
|
$2.72 M
|
$3.10 M
|
$1.34 M
|
$1.49 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$8.93 M
|
$3.09 M
|
$3.87 M
|
$3.67 M
|
$4.55 M
|
$2.98 M
|
$2.18 M
|
| Cost And Expenses |
$8.93 M
|
$3.09 M
|
$3.87 M
|
$3.67 M
|
$4.55 M
|
$2.98 M
|
$2.18 M
|
| Interest Income |
$0.00
|
$5.56 K
|
$482.00
|
$617.00
|
$132.00
|
$38.00
|
$4.00
|
| Interest Expense |
$66.02 K
|
$248.37 K
|
$218.71 K
|
$740.85 K
|
$113.99 K
|
$13.54 K
|
$317.10 K
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| EBITDA |
-$8.58 M |
-$2.19 M |
-$4.56 M |
-$4.22 M |
-$4.09 M |
-$1.64 M |
-$2.73 M |
| EBITDA Ratio |
-393.6
|
0
|
0
|
-18.08
|
-6.4
|
-1.46
|
0
|
| Operating Income Ratio |
-408.73
|
0
|
0
|
-14.71
|
-6.12
|
-1.64
|
0
|
| Total Other Income/Expenses Net |
$263.82 K
|
$651.66 K
|
-$912.92 K
|
-$1.53 M
|
-$293.16 K
|
$196.90 K
|
-$870.06 K
|
| Income Before Tax |
-$8.64 M
|
-$2.44 M
|
-$4.78 M
|
-$4.96 M
|
-$4.20 M
|
-$1.65 M
|
-$3.05 M
|
| Income Before Tax Ratio |
-396.63
|
0
|
0
|
-21.25
|
-6.58
|
-1.47
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$179.17 K
|
$0.00
|
$0.00
|
| Net Income |
-$8.64 M
|
-$2.44 M
|
-$4.78 M
|
-$4.96 M
|
-$4.38 M
|
-$1.65 M
|
-$3.05 M
|
| Net Income Ratio |
-396.63
|
0
|
0
|
-21.25
|
-6.86
|
-1.47
|
0
|
| EPS |
-0.25 |
-0.0848 |
-0.14 |
-0.15 |
-0.44 |
-0.19 |
-0.35 |
| EPS Diluted |
-0.25 |
-0.0848 |
-0.14 |
-0.15 |
-0.44 |
-0.19 |
-0.35 |
| Weighted Average Shares Out |
$34.63 M
|
$28.78 M
|
$32.88 M
|
$32.88 M
|
$9.49 M
|
$8.74 M
|
$8.74 M
|
| Weighted Average Shares Out Diluted |
$34.63 M
|
$28.78 M
|
$32.88 M
|
$32.88 M
|
$9.49 M
|
$8.74 M
|
$8.74 M
|
| Link |
|
|
|
|
|
|
|
